AWA
LLY icon

Aquire Wealth Advisors’s Eli Lilly LLY Stock Holding History

Aquire Wealth Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-591
Closed -$451K – 50
2025
Q3 		$451K Buy
591
+6
+1% +$4.46K 0.11% 34
2025
Q2 		$456K Hold
585
– – 0.12% 33
2025
Q1 		$483K Hold
585
– – 0.15% 31
2024
Q4 		$452K Hold
585
– – 0.14% 33
2024
Q3 		$518K Buy
+585
New +$526K 0.16% 33
2022
Q1 		– Sell
-6
Closed -$2K – 145
2021
Q4 		$2K Buy
+6
New +$1.52K ﹤0.01% 187

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Aquire Wealth Advisors's LLY Position: Q4 2025 in Review

Aquire Wealth Advisors sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 591 shares — an estimated $451K sold.

Aquire Wealth Advisors first reported a position in LLY in Q4 2021 and held it in 6 quarters. The position peaked at $518K in Q3 2024. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Aquire Wealth Advisors reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Aquire Wealth Advisors sold 591 Eli Lilly shares in Q4 2025, an estimated $451K.
  • Aquire Wealth Advisors first reported a position in Eli Lilly in Q4 2021 and held it in 6 quarters.
  • Aquire Wealth Advisors's Eli Lilly position peaked at $518K in Q3 2024.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Aquire Wealth Advisors's 13F filing for Q4 2025, filed 7 Jan 2026.